Literature DB >> 16400620

Pharmacokinetics of oral amlodipine orotate in vagotomized dogs.

Hyun H Kwak1, Jong O Kim, Han K Chung, Seul M Choi, Jung H Kim, Jong W Kwon, Moohi Yoo, Joo H Lee, Myung G Lee.   

Abstract

It was reported that gastric motility was delayed and gastric acid secretion was reduced in vagotomized dogs which mimics a low gastric acidity in humans. A delay in gastric motility causes long residence of amlodipine in the stomach. More unionized fractions of amlodipine could exist in less acidic conditions of gastrointestinal fluids, since amlodipine is a weak basic drug with pKa of 8.7. Hence, gastrointestinal absorption of amlodipine is expected to be enhanced and the time to reach a peak plasma concentration of amlodipine (Tmax) is faster in vagotomized dogs. This was proven after oral administration of an amlodipine orotate tablet at a dose of 5 mg as amlodipine in vagotomized dogs. For example, in vagotomized dogs, the total area under the plasma concentration-time curve from time zero to the last measured time, 48 h, in plasma (AUC(0-48 h)) was significantly greater (725 versus 348 ng h/ml) and Tmax was significantly shorter (1.50 versus 5.00 h) than those in dogs without vagotomy. 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400620     DOI: 10.1002/bdd.495

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  3 in total

1.  Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.

Authors:  Soo-Yun Lee; Jung-Ryul Kim; Jin Ah Jung; Wooseong Huh; Mi Young Bahng; Jae-Wook Ko
Journal:  Drug Des Devel Ther       Date:  2015-06-02       Impact factor: 4.162

2.  Pharmacokinetics Studies of 12 Alkaloids in Rat Plasma after Oral Administration of Zuojin and Fan-Zuojin Formulas.

Authors:  Ping Qian; You-Bo Zhang; Yan-Fang Yang; Wei Xu; Xiu-Wei Yang
Journal:  Molecules       Date:  2017-01-30       Impact factor: 4.411

3.  Fixed Dose Single Tablet Formulation with Differential Release of Amlodipine Besylate and Simvastatin and Its Pharmacokinetic Profile: QbD and Risk Assessment Approach.

Authors:  Ummarah Kanwal; Shahid Mukhtar; Muzzamil Waheed; Arifa Mehreen; Nasir Abbas; Rahat Shamim; Khalid Hussain; Fatima Rasool; Amjad Hussain; Nadeem Irfan Bukhari
Journal:  Drug Des Devel Ther       Date:  2021-05-24       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.